Treating the growing problem of childhood obesity calls for exploring new approaches and treatments through well-designed ...

The guidelines are a first-of-its-kind effort to establish recommendations for the medical management of HS in seven ...

Guideline panel members also considered pediatric-specific concerns such ... Highlights from the ACG’s updated clinical guideline for the diagnosis and management of patients with EoE follow.

Syndax Pharmaceuticals (Nasdaq: SNDX) will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14th at 10:30 a.m. PT/1:30 p.m. ET. Ahead of the presentation, Syndax ...

Most children with asthma in the UK don’t regularly receive guideline-recommended monitoring; when they do, exacerbations are ...

NeurAxis's robust sales growth and disciplined cost management have set the stage for achieving cash flow breakeven in 2026. Notably, recent investments from life science-focused funds have bolstered ...

Autolus Therapeutics (AUTL) announces business updates and an overview of 2025 milestones. Ongoing commercial launch of AUCATZYL on track, with ...

Individualized treatments for cancer show great promise, and three KC-area providers are dialing up their offerings.

NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing ...

Royal College of Physicians (1991) 1991–2000 Aggressive treatment, prophylaxis and investigation of all children aged <7 years [81] American Academy of Pediatrics Guideline (1999) Aggressive ...

U.S. launch expected in early February – – Niktimvo is the first and only approved treatment for chronic GVHD that targets CSF-1R to reduce the drive ...